« Back to Record
Citation APA

Beuselinck, B., Wolter, P., Karadimou, A., Elaidi, R., Dumez, H., Rogiers, A., Van Cann, T., Willems, L., Body, J.-J., Berkers, J., Van Poppel, H., Lerut, E., Debruyne, P., Paridaens, R., & Schöffski, P. (2012). Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. British Journal of Cancer, 107(10), 1665-1671. doi:10.1038/bjc.2012.385


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143043

Beuselinck, B., Wolter, P., Karadimou, A., Elaidi, R., Dumez, H., Rogiers, A., Van Cann, T., Willems, L., Body, J.-J., Berkers, J., Van Poppel, H., Lerut, E., Debruyne, P., Paridaens, R., & Schöffski, P. (2012). Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. British Journal of Cancer, 107(10), 1665-1671. doi:10.1038/bjc.2012.385